PALISADE BIO, INC. (PALI) Free cash flow 2016–2024
PALISADE BIO, INC. (PALI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.2MFY2024 · since FY2016: -$15.7M → -$12.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$12.2M | -9.5% |
| FY2023 | -$11.1M | +16.7% |
| FY2022 | -$13.4M | +9.5% |
| FY2021 | -$14.8M | -209.4% |
| FY2020 | -$4.8M | — |
| FY2018 | -$7.7M | +42.7% |
| FY2017 | -$13.4M | +14.6% |
| FY2016 | -$15.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net incomePALI Net marginPALI Gross profitPALI Gross marginPALI Operating incomePALI Operating marginPALI Operating cash flowPALI Capital expendituresPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →